The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 238-246 , August 2008

Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes

  • Kenneth W. Rundell, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Kenneth W. Rundell, PhD, Director or Respiratory Research and the Human Physiology Laboratory, Keith J. O'Neill Center for Healthy Families, Marywood University, Scranton, PA 18509.
    • ,
  • Joshua B. Slee, MS

Received 10 April 2008 ,Revised 30 May 2008 ,Accepted 2 June 2008.

References 

  1. Anderson SD, Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes?. J Allergy Clin Immunol. 2000;106:419–428
  2. McFadden ER, Gilbert IA. Exercise-induced asthma. N Engl J Med. 1994;330:1362–1367
  3. Beck KC, Offord KP, Scanlon PD. Bronchoconstriction occurring during exercise in asthmatic subjects. Am J Respir Crit Care Med. 1994;149:352–357
  4. Suman OE, Beck KC, Babcock MA, Pegelow DF, Reddan AW. Airway obstruction during exercise and isocapnic hyperventilation in asthmatic subjects. J Appl Physiol. 1999;87:1107–1113
  5. Rundell KW, Spiering BA, Judelson DA, Wilson MH. Bronchoconstriction during cross-country skiing: is there really a refractory period?. Med Sci Sports Exerc. 2003;35:18–26
  6. Anderson SD, Connolly NM, Godfrey S. Comparison of bronchoconstriction induced by cycling and running. Thorax. 1971;26:396–401
  7. Fitch KD, Morton AR. Specificity of exercise in exercise-induced asthma. BMJ. 1971;4:577–581
  8. Mannix ET, Farber MO, Palange P, Galassetti P, Manfredi F. Exercise-induced asthma in figure skaters. Chest. 1996;109:312–315
  9. Provost-Craig MA, Arbour KS, Sestili DC, Chabalko JJ, Ekinci E. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma. 1996;33:67–71
  10. Rundell KW, Wilber RL, Szmedra L, Jenkinson DM, Mayers LB, Im J. Exercise-induced asthma screening of elite athletes: field versus laboratory exercise challenge. Med Sci Sports Exerc. 2000;32:309–316
  11. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc. 2000;32:732–737
  12. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33:208–213
  13. Rundell KW, Jenkinson DM. Exercise-induced bronchospasm in the elite athlete. Sports Med. 2002;32:583–600
  14. Rundell KW. High levels of airborne ultrafine and fine particulate matter in indoor ice arenas. Inhal Toxicol. 2003;15:237–250
  15. Rundell KW, Spiering BA, Evans TM, Baumann JM. Baseline lung function, exercise-induced bronchoconstriction, and asthma-like symptoms in elite women ice hockey players. Med Sci Sports Exerc. 2004;36:405–410
  16. Rundell KW. Pulmonary function decay in women ice hockey players: is there a relationship to ice rink air quality?. Inhal Toxicol. 2004;16:117–123
  17. Sue-Chu M, Larsson L, Moen T, Rennard SI, Bjermer L. Bronchoscopy and bronchoalveolar lavage findings in cross-country skiers with and without “ski asthma. Eur Respir J. 1999;13:626–632
  18. Sue-Chu M, Henriksen AH, Bjermer L. Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics. Respir Med. 1999;93:719–725
  19. Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes. Thorax. 1997;52:157–160
  20. Helenius I, Haahtela T. Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol. 2000;106:444–452
  21. Anderson SD, Sue-Chu M, Perry CP, Gratziou C, Kippelen P, McKenzie DC, et al. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics. J Allergy Clin Immunol. 2006;117:767–773
  22. Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol. 1998;102:722–726
  23. Weiler JM, Ryan EJ. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol. 2000;106:267–271
  24. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. 2007;39:1487–1492
  25. Weiler JM, Bonini S, Coifman R, Craig T, Delgado L, Capão-Filipe M, et al. Ad Hoc Committee of Sports Medicine Committee of American Academy of Allergy, Asthma & Immunology. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol. 2007;119:1349–1358
  26. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161:2086–2091
  27. Henriksen AH, Tveit KH, Holmen TL, Sue-Chu M, Bjermer L. A study of the association between exercise-induced wheeze and exercise versus methacholine-induced bronchoconstriction in adolescents. Pediatr Allergy Immunol. 2002;13:203–208
  28. Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med. 1998;158:1120–1126
  29. Roquet A, Dahlen B, Kumlin M, Ihre E, Anstrén G, Binks S, et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med. 1997;155:1856–1863
  30. National Heart, Lung, and Blood Institute . Expert panel report 2: guidelines for the diagnosis and management of asthma. 1st ed.. Bethesda (MD): NIH Publications; 1997;p. 1-146
  31. Boulet LP, Becker A, Berube A, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Can Med Assoc J. 1999;161(suppl 11):S1–S62
  32. Bye MR, Kerstein D, Barsh E. The importance of spirometry in the assessment of childhood asthma. Am J Dis Child. 1992;146:977–978
  33. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing—1999: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309–329
  34. Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, et al. European Respiratory Society, European Academy of Allergy and Clinical Immunology. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy. 2008;63:387–403
  35. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest. 2003;123:468–474
  36. Newman KB, Mason UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995;152:1382–1386
  37. Evans TM, Rundell KW, Beck KC, Levine AM, Baumann JM. Impulse oscillometry is sensitive to bronchoconstriction after eucapnic voluntary hyperventilation or exercise. J Asthma. 2006;43:49–55
  38. Evans TM, Rundell KW, Beck KC, Levine AM, Baumann JM. Airway narrowing measured by spirometry and impulse oscillometry following room temperature and cold temperature exercise. Chest. 2005;128:2412–2419
  39. Evans TM, Rundell KW, Beck KC, Levine AM, Baumann JM. Cold air inhalation does not affect the severity of EIB after exercise or eucapnic voluntary hyperventilation. Med Sci Sports Exerc. 2005;37:544–549
  40. Anderson SD, Silverman M, Tai E, Godfrey S. Specificity of exercise in exercise-induced asthma. BMJ. 1971;4:814–815
  41. Eggleston PA, Rosenthal RR, Anderson SA, Anderton R, Bierman CW, Bleecker ER, et al. Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. J Allergy Clin Immunol. 1979;64:642–645
  42. Godfrey S, Silverman M, Anderson SD. The use of the treadmill for assessing exercise-induced asthma and the effect of varying the severity and duration of exercise. Pediatrics. 1975;56(5 pt-2 suppl):893–898
  43. König P. Exercise challenge: indications and techniques. Allergy Proc. 1989;10:345–348
  44. Mahler DA. Exercise-induced asthma. Med Sci Sports Exerc. 1993;25:554–561
  45. Warren JB, Jennings SJ, Clark TJ. Effect of adrenergic and vagal blockade on the normal human airway response to exercise. Clin Sci (Lond). 1984;66:79–85
  46. Carlsen KH, Engh G, Mørk M. Exercise-induced bronchoconstriction depends on exercise load. Respir Med. 2000;94:750–755
  47. Haby MM, Anderson SD, Peat JK, Mellis CM, Toelle BG, Woolcock AJ. An exercise challenge protocol for epidemiological studies of asthma in children: comparison with histamine challenge. Eur Respir J. 1994;7:43–49
  48. Ogston J, Butcher JD. A sport-specific protocol for diagnosing exercise-induced asthma in cross-country skiers. Clin J Sport Med. 2002;12:291–295
  49. Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R, McKenzie D, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics. J Allergy Clin Immunol. 2003;111:45–50
  50. Anderson SD, Schoeffel RE. Respiratory heat and water loss during exercise in patients with asthma: effect of repeated exercise challenge. Eur J Respir Dis. 1982;63:472–480
  51. Daviskas E, Gonda I, Anderson SD. Mathematical modeling of heat and water transport in human respiratory tract. J Appl Physiol. 1990;69:362–372
  52. Daviskas E, Gonda I, Anderson SD. Local airway heat and water vapour losses. Respir Physiol. 1991;84:115–132
  53. Stensrud T, Berntsen S, Carlsen KH. Humidity influences exercise capacity in subjects with exercise-induced bronchoconstriction (EIB). Respir Med. 2006;100:1633–1641
  54. Beuther DA, Martin RJ. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest. 2006;129:1188–1193
  55. Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med. 2001;35:344–347
  56. Rundell KW, Anderson SD, Spiering BA, Judelson DA. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest. 2004;125:909–915
  57. Rundell KW, Evans TM, Baumann JM, Kertesz MF. Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation. Can Respir J. 2005;12:257–263
  58. Dickinson JW, Whyte GP, McConnell AK, Harries MG. Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods. Br J Sports Med. 2006;40:179–182discussion 179-82
  59. Spiering BA, Judelson DA, Rundell KW. An evaluation of standardizing target ventilation for eucapnic voluntary hyperventilation using FEV1. J Asthma. 2004;41:745–749
  60. Argyros GJ, Roach JM, Hurwitz KM, Eliasson AH, Phillips YY. Eucapnic voluntary hyperventilation as a bronchoprovocation technique: development of a standarized dosing schedule in asthmatics. Chest. 1996;109:1520–1524
  61. Sterling GM. The mechanism of bronchoconstriction due to hypocapnia in man. Clin Sci. 1968;34:277–285
  62. Finnerty JP, Wilmot C, Holgate ST. Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen: evidence for the predominant role of histamine. Am Rev Respir Dis. 1989;140:593–597
  63. Riedler J, Reade T, Dalton M, Holst D, Robertson C. Hypertonic saline challenge in an epidemiologic survey of asthma in children. Am J Respir Crit Care Med. 1994;150:1632–1639
  64. Rabone SJ, Phoon WO, Anderson SD, Wan KC, Seneviratne M, Gutierrez L, et al. Hypertonic saline challenge in an adult epidemiologic survey. Occup Med. 1996;46:177–185
  65. Anderson SD, Brannan JD, Chan HK. Use of aerosols for bronchial provocation testing in the laboratory: where we have been and where we are going. J Aerosol Med. 2002;15:313–324
  66. Anderson SD, Brannan JD. Methods for “indirect” challenge test including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol. 2003;24:27–54
  67. Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J. 2002;20:301–308
  68. Anderson SD, Brannan JD, Spring J, Spalding N, Rodwell LT, Chan HK, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Cri Care Med. 1997;156:758–765
  69. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B Aridol Study Group. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005;6:144
  70. Sue-Chu M, Henriksen AH, Bjermer L. Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics. Respir Med. 1999;93:719–725
  71. Mohsenin A, Blackburn M. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2006;12:54–59
  72. Currie GP, Jackson CM, Lipworth GJ. Does bronchial hyperresponsiveness in asthma matter?. J Asthma. 2004;41:247–258
  73. Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma. Thorax. 2002;57:323–327
  74. Avraham A, Godfrey S, Springer C. Exercise, methacholine, and adenosine 5'-monophosphate challenges in children with asthma: relation to severity of the disease. Pediatr Pulmonol. 2000;30:207–214
  75. Avital A, Uwyyed K, Berkman N, Bar-Yishay E, Godfrey S, Springer C. Exhaled nitric oxide is age-dependent in asthma. Pediatr Pulmonol. 2003;36:433–438
  76. Benckhuijsen J, Bos JW, Velsen E, Bruijn R, Aalbers R. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5'-monophosphate, and exercise in asthmatic children. Pediatr Pulmonol. 1996;22:147–153
  77. Currie GP, Haggart K, Lee DKC, Fowler SJ, Wilson AM, Branna JD, et al. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy. 2003;33:783–788
  78. van den Berge M, Maijer RJ, Kerstjens HAM, de Reus DM, Koeter GH, Kauffman HF, et al. PC20 adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med. 2001;163:1546–1550
  79. van den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC, de Jongste JC. Adolescents in clinical remission of atopic asthma have elevated nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000;162:953–957
  80. van den Berge M, Kerstjens HA, de Reus DM, Koëter GH, Kauffman HF, Postma DS. Provocation with adenosine 5'-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy. 2004;34:71–76

 (Supported by an educational grant from Merck & Co., Inc.)

 Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD

 Research by K.W.R. is supported by the American Heart Association and the World Anti-Doping Agency. Clinical trials performed in the Human Physiology Laboratory are supported by Forest Laboratories, Merck Inc, Pharmaxis, Schering-Plough, and SkyePharma.

 Terms in boldface and italics are defined in the glossary on page 239.

PII: S0091-6749(08)01137-8

doi: 10.1016/j.jaci.2008.06.014

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 238-246 , August 2008

Article Tools

* Image Usage & Resolution